Literature DB >> 20036167

Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database.

Eva Kumlien1, Per Olov Lundberg.   

Abstract

PURPOSE: To explore the association between the use of neuroactive drugs and reports of epileptic seizures. MATERIAL: Using the WHO adverse drug reactions (ADR) database, VigiBase, we surveyed reports of suspected seizures from 1968 until February 2006. Case reports of ADRs, that were classified as convulsions were collected and compared to the total number of ADRs reported.
RESULTS: The total number of ADRs was 7,375,325. The number of convulsive events was 71,471. The ratio of convulsive ADRs to the total number of ADRs reported for each drug was evaluated and expressed as a percentage. The 10 drugs most frequently associated with convulsive ADRs were maprotilene (14.42%), escitaloprame (9.78%), buproprione (9.49%), clozapine (9.0%), chlorprothiexene (8.89%), amoxapine (8.74%), donepezil (8.40%), rivastigmine (6.41%), quetiapine (5.90%) and trimipramine (5.69%).
CONCLUSIONS: Based on the reports in VigiBase, ADR reports relating to antidepressants, antipsychotic and cholinomimetic drugs included seizures more often than other neuroactive drugs. Copyright 2009 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20036167     DOI: 10.1016/j.seizure.2009.11.005

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  22 in total

Review 1.  Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.

Authors:  Domenico De Berardis; Gabriella Rapini; Luigi Olivieri; Domenico Di Nicola; Carmine Tomasetti; Alessandro Valchera; Michele Fornaro; Fabio Di Fabio; Giampaolo Perna; Marco Di Nicola; Gianluca Serafini; Alessandro Carano; Maurizio Pompili; Federica Vellante; Laura Orsolini; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Ther Adv Drug Saf       Date:  2018-02-06

Review 2.  Elucidating opportunities and pitfalls in the treatment of experimental traumatic brain injury to optimize and facilitate clinical translation.

Authors:  Patricia B de la Tremblaye; Darik A O'Neil; Megan J LaPorte; Jeffrey P Cheng; Joshua A Beitchman; Theresa Currier Thomas; Corina O Bondi; Anthony E Kline
Journal:  Neurosci Biobehav Rev       Date:  2017-05-30       Impact factor: 8.989

3.  Treating epilepsy in the setting of medical comorbidities.

Authors:  Nivedita U Jerath; Dronacharya Lamichhane; Madhu Jasti; Vinusha Yarlagadda; Eduardo Zilli; Yara Nazzal; Mark Granner
Journal:  Curr Treat Options Neurol       Date:  2014-07       Impact factor: 3.598

4.  Comparative analysis of the treatment of chronic antipsychotic drugs on epileptic susceptibility in genetically epilepsy-prone rats.

Authors:  Rita Citraro; Antonio Leo; Rossana Aiello; Michela Pugliese; Emilio Russo; Giovambattista De Sarro
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

Review 5.  Seizure associated with clozapine: incidence, etiology, and management.

Authors:  Andrew M Williams; Susie H Park
Journal:  CNS Drugs       Date:  2015-02       Impact factor: 5.749

6.  Risk of seizures associated with antipsychotic treatment in pediatrics with psychiatric disorders: a nested case-control study in Korea.

Authors:  Soo Min Jeon; Susan Park; Dohoon Kim; Jin-Won Kwon
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-04-07       Impact factor: 4.785

7.  Seizures during antidepressant treatment in psychiatric inpatients--results from the transnational pharmacovigilance project "Arzneimittelsicherheit in der Psychiatrie" (AMSP) 1993-2008.

Authors:  M Köster; R Grohmann; R R Engel; M A Nitsche; E Rüther; D Degner
Journal:  Psychopharmacology (Berl)       Date:  2013-09-26       Impact factor: 4.530

8.  Clozapine prescribing in the UK: views and experience of consultant psychiatrists.

Authors:  Tongeji E Tungaraza; Saeed Farooq
Journal:  Ther Adv Psychopharmacol       Date:  2015-04

9.  Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis.

Authors:  Marlene Bloechliger; Stephan Rüegg; Susan S Jick; Christoph R Meier; Michael Bodmer
Journal:  CNS Drugs       Date:  2015-07       Impact factor: 5.749

10.  Acetylcholinesterase inhibition reveals endogenous nicotinic modulation of glutamate inputs to CA1 stratum radiatum interneurons in hippocampal slices.

Authors:  Manickavasagom Alkondon; Edson X Albuquerque; Edna F R Pereira
Journal:  Neurotoxicology       Date:  2013-03-16       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.